Safely develop SARS-CoV-2 vaccines and antivirals using lentiviral particles pseudotyped with the N501Y Spike protein variant found in mouse-adapted virus.
Based on SBI’s popular and highly cited pPACKH1 Packaging System
Uses codon-optimized SARS-CoV-2 N501Y “S” protein in place of VSV-G envelope protein
Ideal for vaccine and antiviral efficacy studies under BSL2 conditions
Package any 3rd-generation lentivector reporter of your choice, including SBI’s popular LentiLabeler reporters
Use with pPACK-BALD™, an envelope protein-free lentivector packaging system that is an ideal negative control